IP Library › Granted Patent US 12,290,371
Granted Patent B2
US 12,290,371 · App. 17/428,700 · Granted May 6, 2025

Intracalvarial BCI systems and methods for their making, implantation and use

Inventors: Eric Claude Leuthardt (St. Louis, MO); Meron Gribetz (New York City, NY); Daniel W. Moran (Ballwin, MO)
Assignee: Inner Cosmos Inc.
A61B5/369A61B5/0006A61B5/293A61B5/6878A61N1/0531A61N1/36128A61N1/37235A61N1/37514
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,290,371
App. No.
17/428,700
Granted
May 6, 2025
Kind
B2
Abstract

An intra-calvarial implant (ICI) includes a housing including a sealed compartment having a top part, a bottom part and a side wall, and a current directing mechanism extending from the bottom part of the sealed compartment. The ICI also includes one or more electrodes for sensing electrical signals from the brain and/or for electrically stimulating one or more regions of the brain. The ICI includes at least one auxiliary electrode (that may be a reference and/or source/sink electrode) and an electronic circuitry module (ECM), sealingly disposed within the sealed compartment and operatively connected to the one or more electrodes and to the at least one reference electrode. The ECM controls the operation of the ICI and wirelessly communicates with an external telemetry device. The ICI includes a power harvesting device electrically connected to the ECM of the ICI for providing power thereto.

Claims (111)

1. An intra-calvarial implant (ICI) for implantation in a calvarial bone of a mammal having an outer table, a cancellous bone, and an inner table, the ICI comprising:

one or more electrodes for sensing electrical signals from a cortex of a mammal and/or for electrically stimulating one or more regions of a brain of the mammal;

one or more auxiliary electrodes operable as one or more current return electrodes or as one or more reference electrodes or as one or more current return electrodes and one or more reference electrodes;

a housing comprising a sealed compartment having a top part, a bottom part and a side wall extending between the top part and the bottom part, and a current augmenting mechanism, the current augmenting mechanism comprises at least one electrically non-conducting member having a first end sealingly attached to or extending away from the bottom part of the sealed compartment and surrounding the one or more electrodes, the current augmenting mechanism has at least one open end disposed at a second end of the non-conducting member, the open end is configured to direct currents from the one or more electrodes towards the inner table, the current augmenting mechanism is configured to augment the current density in the inner table and in cortical target regions underlying the inner table by reducing or preventing lateral current flow through the electrically non-conducting member from the one or more electrodes to the one or more current return electrodes;

an electronic circuitry module (ECM) sealingly disposed within the sealed compartment and operatively electrically connected to the one or more electrodes and to the one or more auxiliary electrodes, the ECM is configured for controlling the operation of the ICI and for wirelessly communicating with an external telemetry device; and

a power harvesting device suitably electrically connected to the ECM of the ICI for providing power thereto.

2. The ICI according to claim 1 , wherein the current augmenting mechanism is an integral part of the housing or attached to the bottom part of the sealed compartment.

3. The ICI according to claim 1 , wherein the sealed compartment is selected from the following:

a cylindrical sealed compartment having a bottom part having a bottom part diameter, and

a frustoconical shaped sealed compartment having a bottom part with a bottom part diameter and a top part with a top part diameter wherein the top part diameter is larger than the bottom part diameter.

4. The ICI according to claim 1 , wherein the current augmenting mechanism comprises a cylindrically shaped wall having a height H, the cylindrically shaped wall has a first end attached to or extending from the bottom part of the sealed compartment and a second end having a circularly shaped opening with a radius R.

5. The ICI according to claim 4 , wherein H>0.5 R.

6. The ICI according to claim 1 , wherein the current augmenting mechanism comprises a non-cylindrical wall.

7. The ICI according to claim 6 , wherein the cross-sectional shape of the non-cylindrical wall is selected from the group consisting of an oval shape, an elliptical shape, a polygonal shape, an irregular shape and a cross-like shape.

8. The ICI according to claim 1 , wherein the one or more electrodes are attached to an internal surface of the wall of the current augmenting mechanism or disposed adjacent to the internal surface of the wall of the current augmenting mechanism.

9. The ICI according to claim 1 , wherein the one or more auxiliary electrodes are

attached to the bottom part of the sealed compartment and/or attached to the side wall of the sealed compartment.

10. The ICI according to claim 1 , wherein the one or more electrodes are adapted to be implanted between the outer table and the inner table of the calvarial bone without fully penetrating the inner table.

11. The ICI according to claim 1 , wherein the at least one or more auxiliary electrodes is adapted to be disposed on one of the following locations:

between the outer table and the inner table of the calvarial bone;

adjacent to at least part of the outer table of the calvarial bone;

within the cancellous bone of the calvarial bone; and

on top of the housing of the ICI.

12. The ICI according to claim 1 , wherein the at least one or more auxiliary electrodes are selected from one of the following:

a reference electrode and a current return electrode separated from the reference electrode and electrically isolated therefrom;

a reference electrode and a separate current return electrode, wherein the reference electrode is electrically connected to the current return electrode; and

at least one electrode operating as a current return electrode when the ICI is used for stimulating and as a reference electrode when the ICI is used for sensing.

13. The ICI according to claim 4 , wherein the cylindrically shaped wall has a diameter selected from:

the diameter of the cylindrically shaped wall which is smaller than the bottom part diameter of the sealed compartment, and

the diameter of the cylindrically shaped wall which is equal to the bottom part diameter of the sealed compartment.

14. The ICI according to claim 1 , wherein the ICI includes one or more ground electrodes selected from:

a ground electrode attached on the top part of the sealed compartment, and

a ground electrode attached to the side walls of the sealed compartment.

15. The ICI according to claim 1 , wherein the current augmenting mechanism comprises:

a first cylindrically shaped electrically non-conducting wall having a first end attached to or extending from the bottom part of the sealed compartment and a second end having a circularly shaped opening and, the first wall has a first outer diameter, and

a second cylindrically shaped electrically non-conducting wall concentric with the first wall, the second wall has a first end attached to or extending from the bottom part of the sealed compartment and a second end having a circularly shaped opening, the second wall has a second outer diameter, wherein the second outer diameter is smaller than the first outer diameter.

16. The ICI according to claim 15 , wherein the first wall has a first wall height H 1 and the second wall has a second wall height H 2 , and wherein H 1 and H 2 are selected from one of the following relationships:

H 1 =H 2 ;

H 1 >H 2 ; and

H 1 <H 2 .

17. The ICI according to claim 16 , wherein the first wall has an inner surface has a radius R 1 and the second wall has an inner surface has a radius R 2 , and wherein H 1 >0.5R 1 and H 2 >0.5R 2 .

18. The ICI according to claim 15 , wherein the one or more electrodes are selected from one or more of the following:

the one or more electrodes is disposed between the first wall and the second wall;

the one or more electrodes is attached to the first wall; and

the one or more electrodes is attached to the second wall.

19. The ICI according to claim 15 , wherein the outer diameter of the first cylindrically shaped wall is selected from

the outer diameter of the first cylindrically shaped wall is equal to the bottom part diameter of the sealed compartment, and

the outer diameter of the first cylindrically shaped wall is smaller than the bottom part diameter of the sealed compartment.

20. The ICI according to claim 1 , wherein the current augmenting mechanism comprises a plurality of concentric cylindrical walls and wherein the one or more electrodes are disposed between the plurality of walls and/or on an inner surface of the innermost wall of the plurality of walls.

21. The ICI according to claim 1 , wherein, after implantation of the ICI, the one or more electrodes are adapted to be substantially perpendicular to the inner table of the calvarial bone.

22. The ICI according to claim 1 , wherein, after implantation of the ICI, at least one electrode of the one or more auxiliary electrode is adapted to be substantially parallel to the inner table of the calvarial bone.

23. The ICI according to claim 1 , wherein at least some electrodes of the one or more electrodes and the one or more auxiliary electrodes are made from or comprise a material selected from the group consisting of platinum, a platinum/iridium alloy and graphene.

24. The ICI according to claim 1 , wherein the power harvesting device comprises an induction coil electrically connectable to a current conditioning circuit, the current conditioning circuit is selected from a current conditioning circuit formed as an integral part of the ECM and a current conditioning circuit separate from and electrically connected to the ECM.

25. The ICI according to claim 24 , wherein the power harvesting device also includes an electrical charge storage device electrically coupled to the current conditioning circuit and to the ECM.

26. The ICI according claim 24 , wherein the induction coil is located in one of the following locations:

the induction coil disposed within the sealed compartment,

the induction coil integrated into the ECM,

the induction coil disposed outside the sealed compartment, and

the induction coil disposed on or within a shimming member included in the ICI.

27. The ICI according to claim 1 , wherein the ICI also includes a shimming member adapted for attaching to the outer table of the calvarial bone over the top part of the sealed compartment.

28. The ICI according to claim 27 , wherein the shimming member comprises two or more tabs having holes therein for inserting screws into the holes to attach the shimming member claim.

29. The ICI according to claim 27 , wherein the shimming member also comprises a magnet.

30. The ICI according to claim 1 , wherein the ICI is a stimulating ICI and wherein the ECM is programmed for controlling the stimulation of the brain using the one or more electrodes and for wirelessly receiving stimulation control signal from an external telemetry device or from another ICI in wireless communication with the stimulating ICI.

31. The ICI according to claim 1 , wherein the ICI is a sensing/recording ICI and wherein the ECM is programmed to perform one of the following:

controlling the sensing and/or recording of electrical signals from the brain using the one or more electrodes and the at least one reference electrode and for wirelessly transmitting signals recorded from the brain to the external telemetry device or to another ICI in wireless communication with the sensing/recording ICI;

controlling the sensing and/or recording of electrical signals from the brain using the one or more electrodes and the at least one reference electrode, for at least partially processing recorded signals to obtain data and for wirelessly transmitting the data to the external telemetry device, or to another ICI in wireless communication with the sensing/recording ICI; and

controlling the sensing and/or recording of electrical signals from the brain using the one or more electrodes and the at least one reference electrode, for digitizing the recorded signals and for processing digitized signals to detect an indication of a physiological and/or a neurological and/or a neuropsychiatric state of the mammal and for wirelessly transmitting the indication data and/or stimulation control signals to the external telemetry device or to another ICI in communication with the sensing/recording ICI.

32. The ICI according to claim 1 , wherein the ICI is a sensing/recording and stimulating ICI and wherein the ECM is programmed to perform one of the following:

controlling the sensing and/or recording of electrical signals from the brain using the one or more electrodes and the at least one reference electrode and for wirelessly transmitting signals recorded from the brain to the external telemetry device and/or to another ICI in wireless communication with the sensing/recording and stimulating ICI;

controlling the sensing and/or recording of electrical signals from the brain using the one or more electrodes and the at least one reference electrode, for at least partially processing recorded signals to obtain data and for wirelessly transmitting the data to the external telemetry device and/or to another ICI in wireless communication with the sensing/recording and stimulating ICI;

controlling the sensing and/or recording of electrical signals from the brain using the one or more electrodes and the at least one reference electrode, for digitizing the recorded signals and for processing digitized data to detect an indication of a physiological and/or a neurological and/or a neuropsychiatric state of the mammal and for wirelessly transmitting the indication data to an external telemetry device and/or to another ICI in communication with the sensing/recording ICI; and

controlling the sensing and/or recording of electrical signals from the brain using the one or more electrodes and the at least one reference electrode, for digitizing the recorded signals and for processing digitized data for detecting an indication of a physiological and/or a neurological and/or a neuropsychiatric state of the mammal, for autonomously stimulating the brain using the one or more electrodes responsive to the detecting of the indication, for wirelessly communicating with the external telemetry device and/or with another ICI in communication with the sensing/recording and stimulating ICI.

33. The ICI according to claim 1 , wherein the ICI is part of an ICI system comprising at least one more ICI adapted to be implanted in the same calvarial bone.

34. The ICI according to claim 1 , wherein the mammal is a human.

35. The ICI according to claim 1 , wherein the current augmenting mechanism is a multi-channel current augmenting mechanism comprising a plurality of hollow channels.

36. The ICI according to claim 35 , wherein each channel of the plurality of channels has one electrode of the one or more electrodes disposed therein.

37. The ICI according to claim 1 , wherein the power harvesting device is selected from the list consisting of an electromagnetic induction based power harvesting device and an ultrasonic energy based power harvesting device.

38. The ICI according to claim 1 , wherein the current augmenting mechanism comprises a single cylindrically shaped wall having a first end extending from the bottom part of the sealed compartment or attached to the bottom part of the sealed compartment and a second open end, the one or more electrodes for sensing electrical signals from the brain of the mammal and/or for electrically stimulating one or more regions of the brain comprise a stimulating electrode disposed within the current augmenting mechanism, and the one or more auxiliary electrodes comprise a current return electrode.

39. The ICI according to claim 38 , wherein the stimulating electrode is a tubular stimulating electrode disposed within the single cylindrically shaped wall or attached thereto.

40. The ICI according to claim 38 , wherein the current return electrode is disposed on one of the following locations including:

the top part of the sealed compartment,

the bottom part of the sealed compartment, and

the side wall of the sealed compartment.

41. The ICI according to claim 38 , wherein the one or more electrodes of the ICI also include at least one sensing electrode disposed on or attached to the second end of the cylindrically shaped wall and a reference electrode.

42. The ICI according to claim 41 , wherein the reference electrode is disposed on one of the following locations including

the top part of the sealed compartment,

the bottom part of the sealed compartment, and

the side wall of the sealed compartment.

43. The ICI according to claim 38 , wherein the cylindrically shaped wall is configured to be disposed within a tubular shaped passage drilled into the calvarial bone without breaching the inner table of the calvarial bone and wherein the bottom part of the sealed compartment is configured to be attached to an outer surface of the outer table of the calvarial bone.

44. The ICI according to claim 43 , wherein after implantation, the sealed compartment is disposed between the outer table of the calvarial bone and the scalp.

45. An ICI system comprising two or more ICIs, each of the two or more ICIs according to claim 1 , the two or more ICIs are adapted to be implanted in the same calvarial bone of the mammal.

46. The ICI system according to claim 45 , wherein the two or more ICIs are configured for sensing/recording of electrical brain signals and/or electrical brain stimulating.

47. The ICI system according to claim 45 , wherein the two or more ICIs of the ICI system are selected from one of the following:

a master ICI configured for wirelessly receiving sensed brain electrical signals from one or more ICIs of the ICI system, processing the signals to detect an indication of a physiological and/or neurological and/or neuropsychiatric state of the mammal, and for wirelessly controlling brain stimulating operation of the one or more ICIs of the system;

a master ICI configured for wirelessly receiving sensed signals from one or more ICIs of the ICI system, for sensing brain electrical signals, for processing the received signals and the signals sensed by the master ICI to detect an indication of a physiological and/or neurological and/or neuropsychiatric state of the mammal, and for wirelessly controlling the stimulating operation of the one or more ICIs of the system;

a master ICI configured for wirelessly receiving sensed signals from one or more ICIs of the ICI system, for sensing brain electrical signals, for stimulating the brain, for processing the received signals and the signals sensed by the master ICI to detect an indication of a physiological and/or neurological and/or neuropsychiatric state of the mammal, or wirelessly controlling the stimulating operation of the one or more ICIs of the system and for synchronizing the stimulation performed by the one or more ICIs with the stimulation performed by the master ICI;

a master ICI configured for wirelessly receiving sensed signals from one or more ICIs of the ICI system, for sensing brain electrical signals, for processing the received signals and the signals sensed by the master ICI to detect an indication of a physiological and/or neurological and/or neuropsychiatric state of the mammal and for wirelessly controlling the stimulating operation of the one or more ICIs;

a slave ICI configured for performing sensing/recording of brain electrical signals and for wirelessly transmitting sensed signals to a master ICI adapted to be implanted in the same calvarial bone;

a slave ICI configured for stimulating the brain of the mammal and for wirelessly receiving stimulation control signals from a master ICI adapted to be implanted in the same calvarial bone; and

a slave ICI configured for performing sensing/recording of brain electrical signals, for wirelessly transmitting sensed signals to a master ICI adapted to be implanted in the same calvarial bone, for stimulating the brain of the mammal, and for wirelessly receiving stimulation control signals from the master ICI adapted to be implanted in the same calvarial bone.

48. The ICI system according to claim 45 , wherein the one or more ICIs included in the ICI system are configured for wirelessly communicating with an external controller/processor for performing one or more of the following:

transmitting sensed electrical brain signals to the external controller processor; and

receiving stimulation control signals from the external controller/processor.

49. A method of augmenting current flowing from one or more stimulating electrodes of an ICI into a cortex through the inner table of a calvarial bone, the method comprises the steps of,

implanting the ICI according to claim 1 in the calvarial bone such that at least part of the inner table, a pia matter and a dura matter intervene between the cortex underlying an inner table of the calvarial bone and the current augmenting mechanism of the ICI; and

passing a current between at least one electrode of the one or more electrodes and at least one of the one or more auxiliary electrodes.

50. The method according to claim 49 , wherein the current is selected from a cortical stimulating current and a cortical inhibiting current.

51. The method according to claim 49 , wherein the at least on electrode of the one or more electrodes operates as a cathode or an anode.

52. The method according to claim 49 , wherein the current is a pulsed current.

53. The method according to claim 49 , wherein the current augmenting mechanism is adapted to augment one or more parameters including the current's rise-time and the current density within a given cortical tissue volume.

54. The method according to claim 49 , wherein the current augmenting mechanism is adapted to change the spatial distribution pattern of the current flowing into the cortex.

Assignments (3)
CHANGE OF NAME Recorded Sep 28, 2021
From: INNER COSMOS LLC
To: INNER COSMOS INC.
Reel/Frame 057646/0490 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2021
From: LEUTHARDT, ERIC CLAUDE; GRIBETZ, MERON; MORAN, DANIEL W.
To: INNER COSMOS LLC
Reel/Frame 057554/0944 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 13, 2021
From: LEUTHARDT, ERIC CLAUDE; GRIBETZ, MERON; MORAN, DANIEL W.
To: INNER COSMOS INC.
Reel/Frame 057456/0455 →
Continuity (2)
Provisional Application 62802245 · Feb 7, 2019
Related Publication 20220117540A1 · Apr 21, 2022
References Cited (365)
US 4328813A · Ray · 1982 [cited by applicant]
US 4551149A · Sciarra · 1985 [cited by applicant]
US 5895416A · Barreras, Sr. et al. · 1999 [cited by applicant]
US 6178353B1 · Griffith et al. · 2001 [cited by applicant]
US 6246911B1 · Seligman · 2001 [cited by applicant]
US 6463328B1 · John · 2002 [cited by applicant]
US 6782292B2 · Whitehurst · 2004 [cited by applicant]
US 6909917B2 · Woods et al. · 2005 [cited by applicant]
US 7120486B2 · Leuthardt et al. · 2006 [cited by applicant]
US 7177678B1 · Osorio et al. · 2007 [cited by applicant]
US 7346391B1 · Osorio et al. · 2008 [cited by applicant]
US 7353065B2 · Morrell · 2008 [cited by applicant]
US 7532935B2 · Maschino et al. · 2009 [cited by applicant]
US 7890182B2 · Parramon et al. · 2011 [cited by applicant]
US 8065012B2 · Firlik et al. · 2011 [cited by applicant]
US 8121694B2 · Molnar et al. · 2012 [cited by applicant]
US 8262714B2 · Hulvershorn et al. · 2012 [cited by applicant]
US 8380314B2 · Panken et al. · 2013 [cited by applicant]
US 8396557B2 · DiLorenzo · 2013 [cited by applicant]
US 8412334B2 · Whitehurst et al. · 2013 [cited by applicant]
US 8868173B2 · Nelson et al. · 2014 [cited by applicant]
US 8914115B2 · Giftakis et al. · 2014 [cited by applicant]
US 8914119B2 · Wu et al. · 2014 [cited by applicant]
US 8936630B2 · Denison et al. · 2015 [cited by applicant]
US 9079039B2 · Carlson et al. · 2015 [cited by applicant]
US 9084901B2 · Wahlstrand · 2015 [cited by applicant]
US 9173811B2 · Greiner et al. · 2015 [cited by applicant]
US 9198828B2 · Greiner et al. · 2015 [cited by applicant]
US 9327069B2 · Foster et al. · 2016 [cited by applicant]
US 9352145B2 · Whitehurst et al. · 2016 [cited by applicant]
US 9381346B2 · Lee et al. · 2016 [cited by applicant]
US 9409030B2 · Perryman et al. · 2016 [cited by applicant]
US 9511223B2 · DeGiorgio et al. · 2016 [cited by applicant]
US 9566449B2 · Perryman et al. · 2017 [cited by applicant]
US 9597494B2 · Wingeier et al. · 2017 [cited by applicant]
US 9782593B2 · Parramon et al. · 2017 [cited by applicant]
US 9925384B2 · Perryman et al. · 2018 [cited by applicant]
US 9949376B2 · Greenberg et al. · 2018 [cited by applicant]
US 10025375B2 · Lazor et al. · 2018 [cited by applicant]
US 10149958B1 · Tran et al. · 2018 [cited by applicant]
US 10201708B2 · De Ridder · 2019 [cited by applicant]
US 10220211B2 · Liao · 2019 [cited by applicant]
US 10471262B2 · Perryman et al. · 2019 [cited by applicant]
US 11467665B2 · Gribctz · 2022 [cited by applicant]
US 20020087201A1 · Firlik et al. · 2002 [cited by applicant]
US 20060122660A1 · Boveja et al. · 2006 [cited by applicant]
US 20070027499A1 · Maschino et al. · 2007 [cited by applicant]
US 20070043401A1 · John · 2007 [cited by applicant]
US 20070179558A1 · Gliner · 2007 [cited by applicant]
US 20080161880A1 · Firlik et al. · 2008 [cited by applicant]
US 20090112278A1 · Wingeier et al. · 2009 [cited by applicant]
US 20090118804A1 · Moffitt et al. · 2009 [cited by applicant]
US 20090264954A1 · Rise et al. · 2009 [cited by applicant]
US 20100114237A1 · Giftakis et al. · 2010 [cited by applicant]
US 20100280336A1 · Giftakis et al. · 2010 [cited by applicant]
US 20110009922A1 · Assaf et al. · 2011 [cited by applicant]
US 20110137381A1 · Lee et al. · 2011 [cited by applicant]
US 20110264165A1 · Molnar et al. · 2011 [cited by applicant]
US 20110295338A1 · Rickert et al. · 2011 [cited by applicant]
US 20120071947A1 · Gupta et al. · 2012 [cited by applicant]
US 20120108998A1 · Molnar et al. · 2012 [cited by applicant]
US 20120296444A1 · Greenberg et al. · 2012 [cited by applicant]
US 20130178829A1 · Rezai et al. · 2013 [cited by applicant]
US 20140058528A1 · Contreras-Vidal et al. · 2014 [cited by applicant]
US 20140142669A1 · Cook et al. · 2014 [cited by applicant]
US 20140200432A1 · Banerji et al. · 2014 [cited by applicant]
US 20140214125A1 · Greiner et al. · 2014 [cited by applicant]
US 20140237073A1 · Schiff · 2014 [cited by applicant]
US 20140277019A1 · Pearson · 2014 [cited by applicant]
US 20150105837A1 · Aguilar Domingo · 2015 [cited by applicant]
US 20150118661A1 · Haruta · 2015 [cited by applicant]
US 20150119689A1 · Pascual-Leone et al. · 2015 [cited by applicant]
US 20150227702A1 · Krishna · 2015 [cited by applicant]
US 20160206883A1 · Bornzin et al. · 2016 [cited by applicant]
US 20160331968A1 · Greenberg · 2016 [cited by examiner]
US 20160354095A1 · Pearson · 2016 [cited by applicant]
US 20170042474A1 · Widge et al. · 2017 [cited by applicant]
US 20170043167A1 · Widge et al. · 2017 [cited by applicant]
US 20170202475A1 · Leuthardt · 2017 [cited by applicant]
US 20170259064A1 · Wu et al. · 2017 [cited by applicant]
US 20180036537A1 · Van den Heuvel · 2018 [cited by applicant]
US 20180133487A1 · Shah · 2018 [cited by examiner]
US 20180153474A1 · Aeschlimann et al. · 2018 [cited by applicant]
US 20180289311A1 · Phillips · 2018 [cited by applicant]
US 20180353759A1 · Starr et al. · 2018 [cited by applicant]
US 20190090749A1 · Leuthardt et al. · 2019 [cited by applicant]
US 20190216342A1 · Williams et al. · 2019 [cited by applicant]
US 20190217112A1 · Williams et al. · 2019 [cited by applicant]
US 20190217113A1 · Williams et al. · 2019 [cited by applicant]
US 20190217116A1 · Williams et al. · 2019 [cited by applicant]
US 20190346925A1 · Daniels · 2019 [cited by applicant]
US 20200023189A1 · Gribetz et al. · 2020 [cited by applicant]
US 20200330749A1 · Gribetz et al. · 2020 [cited by applicant]
US 20210255707A1 · Gribetz · 2021 [cited by applicant]
US 20210361948A1 · Leuthardt et al. · 2021 [cited by applicant]
US 20220413612A1 · Gribctz · 2022 [cited by applicant]
US 20230075205A1 · Moran · 2023 [cited by applicant]
CA 3098311 · 2019 [cited by applicant]
CN 105916547 · 2016 [cited by applicant]
EP 2835988 · 2015 [cited by applicant]
EP 2038004 · 2018 [cited by applicant]
JP 2009524450 · 2009 [cited by applicant]
JP 2013527784 · 2013 [cited by applicant]
JP 2014079387 · 2014 [cited by applicant]
JP 2016517283 · 2018 [cited by applicant]
WO WO2005039696 · 2005 [cited by applicant]
WO WO2006029007 · 2006 [cited by applicant]
WO WO2007138598 · 2007 [cited by applicant]
WO WO2009044271 · 2009 [cited by applicant]
WO WO2009067323 · 2009 [cited by applicant]
WO WO20100056751 · 2010 [cited by applicant]
WO WO2011123150 · 2011 [cited by applicant]
WO WO2014078074 · 2014 [cited by applicant]
WO WO2014130960 · 2014 [cited by applicant]
WO WO2015164477 · 2015 [cited by applicant]
WO WO2015195553 · 2015 [cited by applicant]
WO WO2016049789 · 2016 [cited by applicant]
WO WO2016118811 · 2016 [cited by applicant]
WO WO2017199052 · 2017 [cited by applicant]
WO WO2018072894A1 · 2018 [cited by examiner]
WO WO2018109715 · 2018 [cited by applicant]
WO WO2019130248 · 2019 [cited by applicant]
WO WO2019239367 · 2019 [cited by applicant]
WO WO2019244099 · 2019 [cited by applicant]
WO WO2020161555 · 2020 [cited by applicant]
WO WO2020225797A1 · 2020 [cited by examiner]
WO WO2021144730 · 2021 [cited by applicant]
Notice of Reason(s) for Rejection Dated Jan. 9, 2024 From the Japan Patent Office Re. Application No. 2020-570860 and Its Translation Into English. (16 Pages). [cited by applicant]
Examination Report Under Sections 12 & 13 of the Patents Act, 1970 and the Patents Rules, 2003 Dated Aug. 12, 2021 From the Government of India, Intellectual Property India, Patents, Designs, Trade Marks, Geographical I… [cited by applicant]
International Preliminary Report on Patentability Dated Jul. 9, 2020 From the International Bureau of WIPO Re. Application No. PCT/IB2018/060667. (8 Pages). [cited by applicant]
International Preliminary Report on Patentability Dated Dec. 24, 2020 From the International Bureau of WIPO Re. Application No. PCT/IB2019/054948. (8 Pages). [cited by applicant]
International Preliminary Report on Patentability Dated Jun. 27, 2019 From the International Bureau of WIPO Re. Application No. PCT/IB2017/057952. (9 Pages). [cited by applicant]
International Preliminary Report on Patentability Dated Apr. 30, 2021 From the International Preliminary Examining Authority Re. Application No. PCT/IB2020/050527. (45 Pages) (Part 1). [cited by applicant]
International Preliminary Report on Patentability Dated Apr. 30, 2021 From the International Preliminary Examining Authority Re. Application No. PCT/IB2020/050527. (45 Pages) (Part 2). [cited by applicant]
International Preliminary Report on Patentability Dated Dec. 30, 2020 From the International Bureau of WIPO Re. Application No. PCT/IB2019/055217. (9 Pages). [cited by applicant]
International Search Report and the Written Opinion Dated Apr. 10, 2019 From the International Searching Authority Re. Application No. PCT/IB2018/060667. (14 Pages). [cited by applicant]
International Search Report and the Written Opinion Dated Dec. 13, 2019 From the International Searching Authority Re. Application No. PCT/IB2019/055217. (15 Pages). [cited by applicant]
International Search Report and the Written Opinion Dated Apr. 16, 2020 From the International Searching Authority Re. Application No. PCT/IB2020/050527. (16 Pages). [cited by applicant]
International Search Report and the Written Opinion Dated Oct. 16, 2019 From the International Searching Authority Re. Application No. PCT/IB2019/054948. (13 Pages). [cited by applicant]
International Search Report and the Written Opinion Dated Mar. 22, 2018 From the International Searching Authority Re. Application No. PCT/IB2017/057952. (16 Pages). [cited by applicant]
International Search Report and the Written Opinion Dated Jun. 23, 2021 From the International Searching Authority Re. Application No. PCT/IB2021/050253. (21 Pages). [cited by applicant]
Invitation to Pay Additional Fees Dated Oct. 15, 2019 From the International Searching Authority Re. Application No. PCT/IB2019/055217. (2 Pages). [cited by applicant]
Invitation to Pay Additional Fees, Communication Relating to the Results of the Partial International Search and the Provisional Opinion Dated May 3, 2021 From the International Searching Authority Re. Application No. P… [cited by applicant]
Written Opinion Dated Dec. 21, 2020 From the International Preliminary Examining Authority Re. Application No. PCT/IB2020/050527. (9 Pages). [cited by applicant]
Albert et al. “Deep Brain Stimulation, Vagal Nerve Stimulation and Transcranial Stimulation: An Overview of stimulation Parameters and Neurotransmitter Release”, Neuroscience & Biobehavioral Reviews,33(7):1042-1060, Jul… [cited by applicant]
Alesci et al. “Major Depression Is Associated with Significant Diurnal Elevations in Plasma Interleukin-6 Levels, a Shift of Its Circadian Rhythm, and Loss of Physiological Complexity in Its Secretion: Clinical Implicat… [cited by applicant]
Allain et al. “Enzymatic Determination of Total Serum Cholesterol”, Clinical Chemistry,20(4): 470-475, Apr. 1974. [cited by applicant]
American Psychiatric Association “Diagnostic and Statistical Manual of Mental Disorders: DSM-IV™”, The American Psychiatric Association, Fourth Ed., p. 1-886, May 1994. [cited by applicant]
Asselbergs et al. “Mobile Phone-Based Unobtrusive Ecological Momentary Assessment of Day-to-Day Mood: An Explorative Study”, Journal of Medical Internet Research,18(3):1-15, 2016. [cited by applicant]
Avery et al. “A Controlled Study of Repetitive Transcranial Magnetic Stimulation in Medication-Resistant Major Depression”, Biological Psychiatry,59(2):187-194, Jan. 15, 2006. [cited by applicant]
Ballenger et al. “Carbamazepine in Manic-Depressive Illness: A New Treatment”, The American Journal of Psychiatry, 137(7): 782-790, Jul. 1980. [cited by applicant]
Barker et al. “Non-Invasive Magnetic Stimulation of Human Moto Cortex”, The Lancet 325:1106-1107, 1985. [cited by applicant]
Behrend et al. “Toward Feedback Controlled Deep Brain Stimulation: Dynamics of Glutamate Release in the Subthalamic Nucleus in Rats”, Journal of Neuroscience Methods, 180(2): 278-289, Jun. 15, 2009. [cited by applicant]
Bejjani et al. “Transient Acute Depression Induced by High-Frequency Deep-Brain Stimulation”, The New England Journal of Medicine, 340:1476-1480,May 13, 1999. [cited by applicant]
Belmaker et al. “Major Depressive Disorder”, The New England Journal of Medicine, 358:55-68,Jan. 3, 2008. [cited by applicant]
Benabid et al. “Combined (Thalamotomy and Stimulation) Stereotactic Surgery of the VIM Thalamic Nucleus for Bilateral Parkinson Disease”,Proceedings of the Meeting of the American Society for Stereotactic and Functional… [cited by applicant]
Ben-Menachem et al. “Effects of Vagus Nerve Stimulation on Amino Acids and Other Metabolites in the CSF of Patients with Partial Seizures”, Epilepsy Research, 20(3):221-227, Mar. 1995. [cited by applicant]
Ben-Menachem et al. “Vagus Nerve Stimulation for Treatment of Partial Seizures: 1. A Controlled Study of Effect on Seizures”, Epilepsia, 35(3):614-626, 1994. [cited by applicant]
Berndt et al. “Expanding the Optogenetics Toolkit: A Naturally Occurring Channel for Inhibitory Optogenetics is Discovered”, Science, 349(6248): 590-591,Aug. 7, 2015. [cited by applicant]
Bhagwagar et al. “Persistent Reduction in Brain Serotonin1A Receptor Binding in Recovered Depressed Men Measured by Positron Emission Tomography with [11C]WAY-100635”, Molecular Psychiatry, 9:386-392, Mar. 24, 2004. [cited by applicant]
Bichot et al. “A Source for Feature-Based Attention in the Prefrontal Cortex”, Neuron 88(4): 832-844, Nov. 18, 2015. [cited by applicant]
Bick et al. “Neuromodulation for Restoring Memory”, Neurosurgical Focus, 40:1-12, May 2016. [cited by applicant]
Biederman et al. “A Fully-Integrated, Miniaturized (0.125 mm [cited by applicant]
Boyden et al. “Millisecond-Timescale, Genetically Targeted Optical Control of Neural Activity”, Nature Neuroscience, 8(9):1263-1268, Sep. 2005. [cited by applicant]
Bradley et al. “Influence of Child Abuse on Adult Depression Moderation by the Corticotropin-Releasing Hormone Receptor Gene”,Arch Gen Psychiatry.65(2):190-200,Feb. 2008. [cited by applicant]
Brody et al. “Regional Brain Metabolic Changes in Patients With Major Depression Treated With Either Paroxetine or Interpersonal Therapy”, Arch Gen Psychiatry.;58(7):631-640, Jul. 2001. [cited by applicant]
Bundy et al. “Decoding Three-Dimensional Reaching Movements Using Electrocorticographic Signals in Humans”, Journal of Neural Engineering, 13(2):1-18, Feb. 23, 2016. [cited by applicant]
Burke et al. “Depression and Cortisol Responses toPpsychological Stress: A Meta-Analysis”, Psychoneuroendocrinology 30(9): 846-856, Oct. 2005. [cited by applicant]
Butson et al. “Current Steering to Control the Volume of Tissue Activated During Deep Brain Stimulation”, Brain Stimulation, 1(1): 7-15, Jan. 2008. [cited by applicant]
Carpenter et al. “Effect of Vagus Nerve Stimulation on Cerebrospinal Fluid Monoamine Metabolites, Norepinephrine, and Gamma-AminobutyricAacid Concentrations in Depressed Patients”, Biological Psychiatry, 56(6): 418-426,… [cited by applicant]
Carroll et al. “Pathophysiology o fHypercortisolism in Depression”, Acta Psychiatrica Scandinavica 115 (Suppl. 433): 90-103, Feb. 2007. [cited by applicant]
Caspi et al. “Influence of Life Stress on Depression: Moderation by a Polymorphism in the 5-HTT Gene”, Science, 301(5631): 386-389, Jul. 18, 2003. [cited by applicant]
Cepoiu et al. “Recognition of Depression by Non-Psychiatric Physicians—A Systematic Literature Review and Meta-Analysis”, Journal of General Internal Medicine,23(1):25-36, Jan. 2008. [cited by applicant]
Cohen et al. “Developing a More Focal Magnetic Stimulator. Part I: Some Basic Principles”, Journal of Clinical Neurophysiology, 8(1):102-111, Jan. 1, 1991. [cited by applicant]
Collinger et al. “High-Performance Neuroprosthetic Control by an Individual with Tetraplegia”, The Lancet, 381(9866): 557-564, Feb. 16-22, 2013. [cited by applicant]
Coppen “The Biochemistry of Affective Disorders”, The British Journa of Psychiatry,113(504):1237-1264, Nov. 1967. [cited by applicant]
Coyne et al. “Prevalence, Depressive Nature, and Comorbidity of Disorders in Primary Care”, General Hospital Psychiatry, 16: 267-276, 1994. [cited by applicant]
Cronin et al. “Task-Specific Somatosensory Feedback via Cortical Stimulation in Humans”, IEEE Transactions on Haptics, 9(4):512-522, Jul. 18, 2016. [cited by applicant]
Dantzer et al. “From Inflammation to Sickness and Depression: When the Immune System Subjugates the Brain”, Nature Reviews Neuroscience, 9:46-56, Jan. 1, 2008. [cited by applicant]
Davidson et al. “Depression: Perspectives from Affective Neuroscience”, Annual Review of Psychology, 53:545-574, Feb. 2002. [cited by applicant]
Deisseroth “Optogenetics: 10 years of Microbial Opsins in Neuroscience”, Nature Neuroscience, 18(9): 1213-1225, Sep. 2015. [cited by applicant]
Deisseroth et al. “Optogenetics”, Nature Methods, 8(1):26-29, Jan. 2011. [cited by applicant]
Depression Guideline Panel “Depression in Primary Care: Detection, Diagnosis, and Treatment”, Journal of American Association of Nurse Practionars, 6(5): 224-238, May 1994. [cited by applicant]
Dimitriu et al. “Neurostimulatory Therapeutics in Management of Treatment-Resistant Depression with Focus on Deep Brain Stimulation”, Mount Sinai Journal of Medicine, 75(3):263-275, Jun. 2008. [cited by applicant]
Dobelle “Artificial Vision for the Blind by Connecting a Television Camera to the Visual Cortex”, ASAIO Journal, 46(1):3-9, Jan.-Feb. 2000. [cited by applicant]
Dobelle et al. “Artificial Vision for the Blind by Electrical Stimulation of the Visual Cortex”, Neurosurgery, 5(4):521-527, Oct. 1, 1979. [cited by applicant]
Dobelle et al. “Artificial Vision for the Blind: Electrical Stimulation of Visual Cortex Offers Hope for a Functional Prosthesis”, Science, 1834123):440-444, Feb. 1, 1974. [cited by applicant]
Dobelle et al. “‘Braille’ Reading by a Blind Volunteer by Visual Cortex Stimulation”, Nature, 259:111-112, Jan. 15, 1976. [cited by applicant]
Dobelle et al. “Phosphenes Produced by Electrical Stimulation of Human Occipital Cortex, and Their Application to the Development of a Prosthesis for the Blind”, The Journal of Physiology, 243(2):553-576, Dec. 1, 1974. [cited by applicant]
Doud et al. “Continuous Three-Dimensional Control of a Virtual Helicopter Using a Motor Imagery Based Brain-Computer Interface”, PLOS One,6(10):1-10, Oct. 26, 2011. [cited by applicant]
Dougherty et al. “A Randomized Sham-Controlled Trial of Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Chronic Treatment-Resistant Depression”, Biological Psychiatry, 78(4):240-248, Aug. 15, 2015. [cited by applicant]
Duman et al. “A Molecular and Cellular Theory of Depression”, Arch Gen Psychiatry,54(7):597-606, 1997. [cited by applicant]
Duman et al. “A Neurotrophic Model for Stress-Related Mood Disorders”, Biological Psychiatry, 59(12):1116-1127, Jun. 15, 2006. [cited by applicant]
Duman et al. “Neuronal Plasticity and Survival in Mood Disorders”, Biological Psychiatry, 48(8): 732-739,Oct. 15, 2000. [cited by applicant]
Dumm et al. “Virtual Electrodes by Current Steering in Retinal Protheses”, Investigational Ophthalmology & Visual Science, 55(12): 8077-8085, Dec. 2014. [cited by applicant]
Ellis et al. “Is Platelet Imipramine Binding Reduced in Depression? A Meta-Analysis”, Biological Psychiatry, 36(5):292-299, Sep. 1, 1994. [cited by applicant]
Emiliani et al. “All-Optical Interrogation of Neural Circuits”, Journal of Neuroscience 35(41):13917-13926, Oct. 14, 2015. [cited by applicant]
Fava “Diagnosis and Definition of Treatment-Resistant Depression”, Biological Psychiatry, 53(8):649-659, Apr. 15, 2003. [cited by applicant]
Feng et al. “Toward Closed-ILop Optimization of Deep Brain Sstmulation for Parkinson's Disease: Concepts and Lessons from a Computational Model”, Journal of Neural Engineering, 4(2):14-21, Feb. 23, 2007. [cited by applicant]
Figiel et al. “The Use of Rapid-Rate Transcranial Magnetic Stimulation (FTMS) in Refractory Depressed Patients”, Journal of Neuropsychiatry, 10(1):20-25, Apr. 2006. [cited by applicant]
Fitzgerald et al. “A Randomized, Controlled Trial of Sequential Bilateral Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression”, The American Journal of Psychiatry, 163(1):88-94,Jan. 2006. [cited by applicant]
Fitzgerald et al. “The Application of Transcranial Magnetic Stimulation in Psychiatry and Neurosciences Research”, Acta Psichiatrica Scandinavica, 105(5( ):324-340, May 2002. [cited by applicant]
Fontaine et al. “Effect of Subthalamic Nucleus Stimulation on Obsessive-Compulsive Disorder in a Patient with Parkinson Disease,” Journal of Neurosurgery 100 (2004):1084-1086. [cited by applicant]
Foster et al. “Reverse Replay of Behavioural Sequences in Hippocampal Place Cells During the Awake State.”, Nature,440: 680-683, Mar. 30, 2006. [cited by applicant]
Frank et al. “Hold Your Horses: Impulsivity, Deep Brain Stimulation, and Medication in Parkinsonism”, Science,318(23):1309-1312, Nov. 2007. [cited by applicant]
Fu et al. “Stable Long-Term Chronic Brain Mapping at the Single-Neuron Level”, Nature Methods,13: 875-882, Aug. 29, 2016. [cited by applicant]
Gale et al. “Electrical Stimulation-Evoked Dopamine Release in the Primate Striatum”, Stereotact Functional Neurosurgery,91(6):355-363, Nov. 2013. [cited by applicant]
Gale et al. “Reward and Reinforcement Activity in the Nucleus Accumbens During Learning”, Frontiers in Behavioral Bioscience, 8, Art. 114: 1-10, Apr. 2014. [cited by applicant]
Garrett et al. “EVestG(TM): Responses in Depressed Patients,” 30th Annual International IEEE EMBS Conference Vancouver, British Columbia, Canada, Aug. 20-24, 2008, pp. 1707-1710. [cited by applicant]
George et al. “A One-Year Comparison of Vagus Nerve Stimulation with Treatment as Usual for Treatment-Resistant Depression”, Biological Psychiatry, 58(5):364-373,Sep. 1, 2005. [cited by applicant]
George et al. “Vagus Nerve Stimulation: A New Tool for Brain Research and Therapy”, Biological Psychiatry, 47(4):287-295,Feb. 15, 2000. [cited by applicant]
Goldapple et al. “Modulation of Cortical-Limbic Pathways in Major Depression: Treatment-Specific Effects of Cognitive Behavior Therapy”, Arch Gen Psychiatry,61(1):34-41, 2004. [cited by applicant]
Golier et al. “Low Serum Cholesterol Level and Attempted Suicide”, The American Journal of Psychiatry, 152(3):419-423, Apr. 2006. [cited by applicant]
Goodman et al. “Deep Brain Stimulation in Psychiatry: Concentrating on the Road Ahead”, Biological Psychiatry, 65(4):263-266,Feb. 15, 2009. [cited by applicant]
Greenberg et al. “Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive-Compulsive Disorder”, Neuropsychopharmacology, 31:2384-2393, Jul. 19, 2006. [cited by applicant]
Grossman et al. “Noninvasive Deep Brain Stimulation via Temporally Interfering Electric Fields”, Cell,169(6): 1029-1041, Jun. 1, 2017. [cited by applicant]
Hacker et al. “Frequency-Specific Electrophysiologic Correlates of Resting State fMRI Networks”, NeuroImage, 149: 446-457, Apr. 1, 2017. [cited by applicant]
Hacker et al. “Resting State Network Estimation in Individual Subjects”, NeuroImage, 82: 616-633, Available Online Jun. 2, 2013. [cited by applicant]
Haelbig et al. “Pallidal Stimulation in Dystonia: Effects on Cognition, Mood, and Quality of Life”, Journal of Neurology, Neurosurgery and Psychiatry,76(12):1713-1716, 2005. [cited by applicant]
Hamilton etal. “Neural Signal Processing and Closed-Loop Control Algorithm Design for an Implanted Neural Recording and Stimulation System”, 37th Annual International Conference of the IEEE Engineering in Medicine and B… [cited by applicant]
Han et al. “Microelectrode Technologies for Deep Brain Stimulation”, Implantable Neural Proteses, 1. Devices and Applications, p. 195-219, Jun. 10, 2009. [cited by applicant]
Hardesty et al. “Deep Brain Stimulation in Movement and Psychiatric Disorders”, Biological Psychiatry, 61(7):831-835, Apr. 1, 2007. [cited by applicant]
Heils et al. “Allelic Variation of Human Serotonin Transporter Gene Expression”, Journal of Neurochemistry, 66(6):2621-2624, Jun. 1996. [cited by applicant]
Henry et al. “Brain Blood Flow Alterations Induced by Therapeutic Vagus Nerve Stimulation in Partial Epilepsy: I. Acute Effects at High and Low Levels of Stimulation”, Epilepsia, 39(9):983-990, Sep. 1998. [cited by applicant]
Hochberg et al. “Neuronal Ensemble Control of Prosthetic Devices by a Human with Tetraplegia”, Nature, 442:164-171, Jul. 13, 2006. [cited by applicant]
Holsboer “The Corticosteroid Receptor Hypothesis of Depression”, Neuropsychopharmacology, 23:477-501, Nov. 1, 2000. [cited by applicant]
Holsboer et al. “Antidepressants and Hypothalamic-Pituitary-Adrenocortical Regulation”, Endocrine Reviews, 17(2):187-205, Apr. 1, 1996. [cited by applicant]
Hong et al. “Syringe Injectable Electronics: Precise Targeted Delivery with Quantitative Input/Output Connectivity”, Nano Letters, 15 (10): 6979-6984, 2015. [cited by applicant]
Jacobs et al. “Adult Brain Neurogenesis and Psychiatry: A Novel Theory of Depression”, Molecular Psychiatry,5:262-269, Jun. 15, 2000. [cited by applicant]
Janicak et al. “Transcranial Magnetic Stimulation in the Treatment of Major Depressive Disorder: A Comprehensive Summary of Safety Experience From Acute Exposure, Extended Exposure, and During Reintroduction Treatment”,… [cited by applicant]
Jarosiewicz et al. “Virtual Typing by People with Tetraplegia Using a Self-Calibrating Intracortical Braincomputer Interface”, Science Translational Medicine 11;7(313):28P. Nov. 2015. [cited by applicant]
Jiminez et al. “A Patient with a Resistant Major Depression Disorder Treated with Deep Brain Stimulation in the Inferior Thalamic Peduncle”, Neurosurgery, 57(3):585-593, Sep. 1, 2005. [cited by applicant]
Judd et al. “A Prospective 12-Year Study of Subsyndromal and Syndromal Depressive Symptoms in Unipolar Major Depressive Disorders”, Arch Gen Psychiatry,55(8):694-700, Aug. 1998. [cited by applicant]
Karege et al. “Decreased Serum Brain-Derived Neurotrophic Factor Levels in Major Depressed Patients”, Psychiatry Research, 109(2):143-148, Mar. 15, 2002. [cited by applicant]
Katnani et al. Temporally Coordinated Deep Brain Stimulation in the Dorsal and Ventral Striatum Synergistically Enhances Associative Learning, Scientific Reports, 6:1-8, Jan. 4, 2016. [cited by applicant]
Kearns et al. “A Comparison of Depression Rating Scales”, The British Journal of Psychiatry, 141(1): 45-49, Jul. 1982. [cited by applicant]
Kempermann et al. “Depressed New Neurons?—Adult Hippocampal Neurogenesis and a Cellular Plasticity Hypothesis of Major Depression”, Biological Psychiatry, 54(5):499-503, Sep. 1, 2003. [cited by applicant]
Kendler et al. “The Interaction of Stressful Life Events and a Serotonin Transporter Polymorphism in the Prediction of Episodes of Major Depression”, Arch Gen Psychiatry, 62(5):529-535, May 2005. [cited by applicant]
Kennedy et al. “Direct Control of a Computer from the Human Central Nervous System”, IEEE Transactions on Rehabilitation Engineering, 8(2): 198-202, Jun. 2000. [cited by applicant]
Kessler et al. “Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication”, Archives of General Psychiatry, 62(6): 593-602, Jun. 2005. [cited by applicant]
Kessler et al. “The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R)”, JAMA, 289(23):3095-3105, Jun. 18, 2003. [cited by applicant]
Kirsch et al. “Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration”, PLOS Medicine, 5(2):260-268, Feb. 2008. [cited by applicant]
Kirsch et al. “The Emperor's New Drugs: An Analysis of Antidepressant Medication Data Submitted to the U.S. Food and Drug Administration”, Prevention & Treatment,5, (Art.23):1-11, Jul. 15, 2002. [cited by applicant]
Klein et al. Therapeutic Efficacy of Right Prefrontal Slow Repetitive Transcranial Magnetic Stimulation in Major Depression, A Double-Blind Controlled Study: Arch Gen Psychiatry. 56(4):315-320, 1999. [cited by applicant]
Klomp et al. “Fabrication of Large Arrays of Cortical Electrodes for Use in Man”, Journal of Biomedical Materials Research Banner, 11(3):347-364, May 1977. [cited by applicant]
Konsman et al. “Rat brain vascular distribution of interleukin-1 type-1 receptor immunoreactivity: relationship to patterns of inducible cyclooxygenase expression by peripheral inflammatory stimuli”, The Journal of Comp… [cited by applicant]
Kosel et al. “Mood Improvement After Deep Brain Stimulation of the Internal Globus Pallidus for Tardive Dyskinesia in a Patient Suffering From Major Depression”, Journal of Psychiatric Research, 41(9):801-803, Nov. 2007. [cited by applicant]
Krahl et al. “Locus Coeruleus Lesions Suppress the Seizure-Attenuating Effects of Vagus Nerve Stimulation”, Epilepsia, 39(7):709-714 Jul. 1998. [cited by applicant]
Kroenke et al. “The PHQ-9 Validity of a Brief Depression Severity Measure”, Journal of General Internal Medicine Banner, 16(9): 606-613, Sep. 2001. [cited by applicant]
Kucewicz et al. “Evidence for Verbal Memory Enhancement with Electrical Brain Stimulation in the Lateral Temporal Cortex”, Brain, a Journal of Neurology, 141(4); 971-978, Apr. 2018. [cited by applicant]
Kunugi et al. “Low Serum Cholesterol in Suicide Attempters”, 41(2):196-200, Jan. 15, 1997. [cited by applicant]
Lacassse et al. “Serotonin and Depression: A Disconnect between the Advertisements and the Scientific Literature”, PLOS Mdicine, 2(12):1211-1216, Dec. 2005. [cited by applicant]
Leuthardt et al. “A Brain-Computer Interface Using Electrocorticographic Signals in Humans”, Journal of Neural Engineering 1(2): 63-71,Jun. 14, 2004. [cited by applicant]
Lewis et al. “Restoration of Vision in Blind Individuals Using Bionic Devices: A Review with a Focus on Cortical Visual Prostheses”, Brain Research, 1595: 51-73, Jan. 21, 2015. [cited by applicant]
LiKamWa et al. “MoodScope: Building a Mood Sensor from Smartphone Usage Patterns”, MobiSys '13 Proceeding of the 11th Annual International Conference on Mobile Systems, Applications, and Services: 389-402, Jun. 25-28, 2… [cited by applicant]
Liu et al. “Syringe Injectable Electronics”, Nature Nanotechnology, 10(7): 629-636,Jul. 2015. [cited by applicant]
Lozano et al. “Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression”, Biological Psychiatry, 64(6):461-467, Sep. 15, 2008. [cited by applicant]
Maier et al. “S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study”, Disease Markers, 2018(Art.ID 2358451): 1-8, Published Online Jan. 10,… [cited by applicant]
Makris et al. Variability and Anatomical Specificity of the Orbitofrontothalamic Fibers of Passage in the Ventral Capsule/Ventral Striatum (VC/VS): Precision Care for Patient-specific Tractography-Guided Targeting of De… [cited by applicant]
Malone, Jr. et al. “Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression”, Biological Psychiatry, 65(4):267-275, Feb. 15, 2009. [cited by applicant]
Manji et al. “The Cellular Neurobiology of Depression”, Nature Medicine, 7:541-547, May 1, 2001. [cited by applicant]
Mann “The Medical Management of Depression”, The New England Journal of Medicine, 353:1819-1834, Oct. 27, 2005. [cited by applicant]
Marangell et al. “Neurostimulation Therapies in Depression: A Review of New Modalities”, Acta Psychiatrica Scandinavica, 116(3):174-181, Sep. 2007. [cited by applicant]
Marangell et al. “Vagus Nerve Stimulation (VNS) for Major Depressive Episodes: One Year Outcomes”, Biological Psychiatry, 51(4):280-287, Feb. 15, 2002. [cited by applicant]
Martin et al. “Brain Blood Flow Changes in Depressed Patients Treated With Interpersonal Psychotherapy or Venlafaxine Hydrochloride”, Arch Gen Psychiatry.;58(7):641-648, Jul. 2001. [cited by applicant]
Mayberg “Limbic-Cortical Dysregulation: A Proposed Model of Depression”, Clinical Neurosciences, 9(3), 471-481, 1997. [cited by applicant]
Mayberg et al. “Deep Brain Stimulation for Treatment-Resistant Depression”, Neuron, 45(5):651-660, Mar. 3, 2005. [cited by applicant]
Mayberg et al. “Reciprocal Limbic-Cortical Function and Negative Mood: Converging PET Findings in Depression and Normal Sadness”, The American Journal of Psychiatry, 156(5):675-682, May 1, 1999. [cited by applicant]
Mayberg et al. “Regional Metabolic Effects of Fluoxetine in Major Depression: Serial Changes and Relationship to Clinical Response”, Biological Psychiatry, 48(8):830-843,Oct. 15, 2000. [cited by applicant]
McCreery et al. “A Characterization of the Effects of Neuronal Excitability Due to Prolonged Microstimulation with Chronically Implanted Microelectrodes”, IEEE Transactions on Biomedical Engineering, 44(10):931-939, Oct… [cited by applicant]
Merali et al. “Dysregulation in the Suicide Brain: mRNA Expression of Corticotropin-Releasing Hormone Receptors and GABAA Receptor Subunits in Frontal Cortical Brain Region”, The Journal of Neuroscience, 24(6):1478-1485… [cited by applicant]
Milak et al. “Neuroanatomic Correlates of Psychopathologic Components of Major Depressive Disorder”, Arch Gen Psychiatry, 62(4):397-408, Apr. 2005. [cited by applicant]
Moessner et al. “Consensus Paper of the WFSBP Task Force on Biological Markers: Biological Markers in Depression”, The World Journal of Biological Psychiatry, 8(3):141-174, 2007. [cited by applicant]
Moran et al. “Motor Cortical Representation of Speed and Direction During Reaching”, Journal of Neurophysiology, 82(5): 2676-2692, Nov. 1, 1999. [cited by applicant]
Morikawa et al. “An Origami-Inspired Ultrastretchable Bioprobe Film Device”, IEEE 29th International Conference on Micro Electro Mechanical Systems (MEMS):149-152, Jan. 2016. [cited by applicant]
Mueller et al. “Recurrence After Recovery From Major Depressive Disorder During 15 Years of Observational Follow-Up”, The American Journal of Psychiatry, 156(7):1000-1006, Jul. 1999. [cited by applicant]
Muller et al. “Thin-Film, Ultra High-Density Microelectrocorticographic Decoding of Speech Sounds in Human Superior Temporal Gyrus”, IEEE Engineering in Medicine and Biology Conference Orlanda,6P, Feb. 2016. [cited by applicant]
Naples et al. “A Spiral Nerve Cuff Electrode for Peripheral Nerve Stimulation”, IEEE Transactions on Biomedical Engineering, 35(11): 905-916, Nov. 1988. [cited by applicant]
Nemeroff et al. “Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients”, Science, 226(4680):1342-1344, Dec. 14, 1984. [cited by applicant]
Nemeroff et al. “VNS Therapy in Treatment-Resistant Depression: Clinical Eviedence and Putative Neurobiological Mechanisms”, Neuropsychopharmacology, 31:1345-1355, Apr. 19, 2006. [cited by applicant]
Nestler et al. “Neurobiology of Depression”, Neuron, 34(1):13-25, Mar. 28, 2002. [cited by applicant]
Neuronetics “NeuroStar TMS Therapy® System: FDA-Cleared Transcranial Magnetic Stimulation for Treatment of Depression”, Neuronetics, 3 P., Sep. 2, 2011. [cited by applicant]
Nibuya et al. “Regulation of BDNF and trkB mRNA in Rat Brain by Chronic Electroconvulsive Seizure and Antidepressant Drug Treatments”, Journal of Neuroscience, 15(11):7539-7547, Nov. 1, 1995. [cited by applicant]
Nuttin et al. “Electrical Stimulation in Anterior Limbs of Internal Capsules in Patients with Obsessive-Compulsive Disorder”, Lancet, 354,(9189):1526, Oct. 30, 1999. [cited by applicant]
Nuyujukian et al. “A Nonhuman Primate Brain-Computer Typing Interface”, Proceedings of the IEEE,105(1):66-72, Sep. 12, 2016. [cited by applicant]
O'Brien et al. “Plasma Cytokine Profiles in DSepressed Patients Who Fail to Respond to Selective Serotonin Reuptake Inhibitor Therapy”, Journal of Psychiatric Research, 41(3-4):326-331, Apr.-Jun. 2007. [cited by applicant]
Ongur et al. “Prefrontal Cortical Projections to the Hypothalamus in Macaque Monkeys”, The Journal of Comparative Neurology,401(4):480-505, Nov. 30, 1998. [cited by applicant]
Oxley et al. “Minimally Invasive Endovascular Stentelectrode Array for High-Fidelity, chronic Recordings of Cortical Neural Activity”, Nature Biotechnology, 34: 320-327, Feb. 8, 2016. [cited by applicant]
Palopoli-Trojani et al. “In Vitro Assessment of Long-Term Reliability of Low-Cost [Mu]ECoG Arrays”, 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBC, Orlando, FL, USA, A… [cited by applicant]
Paniccia et al. “Clinical and Non-Clinical Depression and Anxiety in Young People: A Scoping Review on Heart Rate Variability”, Autonomic Neuroscience: Basic and Clinical, 208: 1-14, Published Online Aug. 26, 2017. [cited by applicant]
Park et al. “Closed-Loop, Ultraprecise, Automated Craniotomies”, Journal of Neurophysiology 113: 3943-3953, Jun. 2015. [cited by applicant]
Pascual-Marquis et al. “Low Resolution Electromagnetic Tomography: A New Method for Localizing Electrical Activity in the Brain”, International Journal of Psychophysiology, 18(1):49-65, Oct. 1994. [cited by applicant]
Peretti et al. “Safety and Tolerability Considerations: Tricyclic Antidepressants vs. Selective Serotonin Reuptake Inhibitors”,Acta Psychiatrica Scandinavica, 101(Suppl.403):17-25, Sep. 2000. [cited by applicant]
Petridis et al. “Unobtrusive Low Cost Pupil Size Measurements Using Web Cameras”, 2nd International Workshop on Artificial Intelligence and Netmedicine (NetMed'13):9-20, Nov. 28, 2013. [cited by applicant]
Piallat et al. “Monophasic But Not Biphasic Pulses Induce Brain Tissue Damage During Monopolar High-Frequency Deep Brain Stimulation”, Neurosurgery, 64(1):156-163, Jan. 1, 2009. [cited by applicant]
Pittenger et al. “Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms”, Neuropsychopharmacology, 33:88-109, 2008. [cited by applicant]
Pool et al. “Psychosurgery in Oler People”, Journal of American Geriatrics Society (AGS), 2(7): 456-466, Jul. 1954. [cited by applicant]
Post et al, “Antidepressant effects of carbamazepine”, Journal of Psychiatry, 143(1): 29-34, Jan. 1986. [cited by applicant]
Quitkin et al. “Study Duration in Antidepressant Research: Advantages of a 12-Week Trial”, Journal of Psychiatric Research, 20(3):211-216,Jan. 1, 1986. [cited by applicant]
Raisman et al. “High-Affinity 3H-Imipramine Binding in Platelets From Untreated and Treated Depressed Patients Compared to Healthy Volunteers”, Psychopharmacology, 75(4):368-371, Dec. 1981. [cited by applicant]
Raison et al. “Cytokines Sing the Blues: Inflammation and the Pathogenesis of Depression”, 27(1):24-31, Jan. 2006. [cited by applicant]
Rechlin et al. “Are Affective Disorders Associated with Alterations of Heart Rate Variability?”, Journal of Affective Disorders,32(4): 271-275, Dec. 1994. [cited by applicant]
Rubin et al. “Neuroendocrine Aspects of Primary Endogenous Depression”, Arch Gen Psychiatry, 44(4):328-336, Apr. 1987. [cited by applicant]
Ruhe et al. “Mood Is Indirectly Related to Serotonin, Norepinephrine and Dopamine Levels in Humans: A Meta-Analysis of Monoamine Depletion Studies”, Molecular Psychiatry, 12:331-359,Jan. 16, 2007. [cited by applicant]
Rush “About Treatment Resistant Depression”, Cyberonics, 2007. [cited by applicant]
Rush et al. “Vagus Nerve Stimulation (VNS) for Treatment-Resistant Depressions: A Multicenter Study”, Biological Psychiatry, 47(4):276-286, Feb. 15, 2000. [cited by applicant]
Russel “A Circumplex Model of Affect”, Journal of Prsonality and Social Psychology, 39(6): 1161-1178, 1980. [cited by applicant]
Sapolsky “Glucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders”, Arch Gen Psychiatry. 57(10):925-935, Oct. 2000. [cited by applicant]
Schalk et al. “Brain-Computer Interfaces Using Electrocorticographic Signals”, IEEE Reviews in Biomedical Engineering, 4:140-154, Oct. 17, 2011. [cited by applicant]
Scherer et al. “Self-Reported Symptoms of Depression and PTSD Are Associated with Reduced Vowel Space in Screening Interviews”, IEEE Transactions on Affective Computing, 7(1): 59-61, Jan.-Mar. 2016. [cited by applicant]
Schwartz et al. “Primate Motor Cortex and Free Arm Movements to Visual Targets in Three-Dimensional Space. I. Relations Between Single Cell Discharge and Direction of Movement”, The Journal of Neuroscience, 8(8): 2913-2… [cited by applicant]
Seo et al. “Wireless Recording in the Peripheral Nervous System with Ultrasonic Neural Dust”, Neuron,91(3): 529-539, Aug. 3, 2016. [cited by applicant]
Sgoifo et al. “Autonomic Dysfunction and Heart Rate Variability in Depression”, Stress, 18(3): 343-352, Published Online May 25, 2015. [cited by applicant]
Shimizu et al. “Alterations of Serum Levels of Brain-Derived Neurotrophic Factor (BDNF) in Depressed Patients With or Without Antidepressants”, Biological Psychiatry, 54(1):70-75, Jul. 1, 2003. [cited by applicant]
Siddiqi et al. “Repetetive Transcranial Magnetic Stimulation With Resting-State Network Targeting for Treatment-Resistant Depression in Traumatic Brain Injury: A Randomized, Controlled, Double-Blinded Pilot Study”, Jour… [cited by applicant]
Silk et al. “Pupillary Reactivity to Emotional Information in Child and Adolescent Depression: Links to Clinical and Ecological Measures”, The American Journal of Psychiatry, 164(12): 1873-1880, Dec. 2007. [cited by applicant]
Smith “The Macrophage Theory of Depression”, Medical Hypotheses, 35(4):298-306, Aug. 1991. [cited by applicant]
Smith et al. “A Bayesian statistical analysis of behavioral facilitation associated with deep brain stimulation”, Journal of Neuroscience Methods, 183(2):267-276,Oct. 15, 2009. [cited by applicant]
Solomon et al. “Multiple Recurrences of Major Depressive Disorder”, The American Journal of Psychiatry, 157(2):229-233, Feb. 2000. [cited by applicant]
Speer et al. “Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients”, Biological Psychiatry, 48(12): 1133-1141,Dec. 15, 2000. [cited by applicant]
Sullivan et al. “Genetic Epidemiology of Major Depression: Review and Meta-Analysis”, The American Journal of Psychiatry, 157(10):1552-1562, Oct. 2000. [cited by applicant]
Sun et al. “Responsive Cortical Stimulation for the Treatment of Epilepsy”, Neurotherapeutics,5(1):68-74, Jan. 2008. [cited by applicant]
Taylor et al. “Direct Cortical Control of 3D Neuroprosthetic Devices”, Science, 296, (5574):1829-1832, Jun. 7, 2002. [cited by applicant]
Troncoso et al. “Vision's First Steps: Anatomy, Physiology, and Perception in the Retina, Lateral Geniculate Nucleus, and Early Visual Cortical Areas”, Visual Prosthetics: 23-57, Jan. 4, 2011. [cited by applicant]
Tung et al. “Using Finite State Automata to Produce Self-Optimization and Self-Control”, IEEE Transactions on Parallel and Distributed Systems, 7(4):439-448, Apr. 1996. [cited by applicant]
Turner et al. “Selective Publication of Anti-Depressant Trials and its Influence on Apparent Efficacy”, The New England Journal of Medicine, 358:252-260, Jan. 17, 2008. [cited by applicant]
Van Rijsbergen et al. “Can a One-Item Mood Scale Do the Trick? Predicting Relapse over 5.5-Years in Recurrent Depression”, PLOS One, 7(10):1-5, Oct. 3, 2012. [cited by applicant]
Velasco et al. “Neurobiological Background for Performing Surgical Intervention in the Inferior Thalamic Peduncle for Treatment of Major Depression Disorders”, Neurosurgery, 57(3):439-448,Sep. 1, 2005. [cited by applicant]
Viventi et al. “Flexible, Foldable, Actively Multiplexed, High-Density Electrode Array for Mapping Brain Activity In Vivo”, Nature Neuroscience, 14(12): 1599-1605, 2011. [cited by applicant]
Wang et al. “An Electrocorticographic Brain Interface in an Individual with Tetraplegia”, PLOS One 8(2):1-8, Feb. 6, 2013. [cited by applicant]
Watanabe et al. “Transcranial Electrical Stimulation Through Screw Electrodes for Intraoperative Monitoring of Motor Evoked Potentials”, Journal of Neurosurgery 100(1):155-160, Jan. 1, 2004. [cited by applicant]
Wells et al. “The Functioning and Well-Being of Depressed Patients: Results From the Medical Outcomes Study”, JAMA, 262(7):914-919, Aug. 18, 1989. [cited by applicant]
Wheeler et al. “An Implantable 64-Channel Neural Interface With Reconfigurable Recording and Stimulation”, 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 7837-7840, … [cited by applicant]
Wodlinger et al. “Ten-Dimensional Anthropomorphic Arm Control in a Human Brain-Machine Interface: Difficulties, Solutions, and Limitations”, Journal of Neural Engineering, 12(1):1-17, Dec. 16, 2014. [cited by applicant]
Wong et al. “Closed-Loop Control of Cellular Functions Using Combinatory Drugs Guided by a Stochastic Search Algorithm”, Proceedings of the National Academy of Sciences, 105(13): 5105-5110, Apr. 1, 2008. [cited by applicant]
Xie et al. “Three-Dimensional Macroporous Nanoelectronic Networks as Minimally Invasive Brain Probes”, Nature Materials, 14: 286-1292 Oct. 5, 2015. [cited by applicant]
Yamagiwa et al. “Flexible Parylene-Film Optical Waveguide Arrays”, Applied Physics LKetters, 107(8), 6P, 2015. [cited by applicant]
Yamagiwa et al. “Self-Curling and -Sticking Flexible Substrate for ECOG Electrode Array”, IEEE 26th International Conference on Micro Electro Mechanical Systems (MEMS): 480-483, Jan. 2013. [cited by applicant]
Yanagisawa et al. “Electrocorticographic Control of a Prosthetic Arm in Paralyzed Patients”, Annals of Neurology,71(3): 353-361, Mar. 2012. [cited by applicant]
Yirmiya et al. “Illness, Cytokines, and Depression”, Annals of the New York Academy of Sciences, 917(1):478-487, Jan. 2000. [cited by applicant]
Yousry et al. “Localization of the Motor Hand Area to a Knob on the Precentral Gyrus, a New Landmark”, Brain, 120(1): 141-157, Jan. 1, 1997. [cited by applicant]
Zhou et al. “Pulvinar-Cortex Interactions in Vision and Attention”, Neuron,89(1): 209-220, Jan. 6, 2016. [cited by applicant]
Official Action Dated Oct. 26, 2023 from the US Patent and Trademark Office Re. U.S. Appl. No. 17/253,176. (17 pages). [cited by applicant]
Translation Dated May 3, 2024 of Grounds of Reason of Rejection Dated Apr. 25, 2024 From the Korean Intellectual Property Office Re. Application No. 10-2021-7001558 (6 Pages). [cited by applicant]
Notice of Reason(s) for Rejection Dated Jun. 20, 2023 From the Japan Patent Office Re. Application No. 2020-570860 and Its Translation Into English. (8 Pages). [cited by applicant]
Restriction Official Action Dated Feb. 2, 2023 from the US Patent and Trademark Office Re. U.S. Appl. No. 17/253,176. (7 pages). [cited by applicant]
Final Official Action Dated Feb. 16, 2023 from the US Patent and Trademark Office Re. U.S. Appl. No. 16/469,165. (33 pages). [cited by applicant]
Official Action Dated May 23, 2024 from the US Patent and Trademark Office Re. U.S. Appl. No. 17/253,176. (14 pages). [cited by applicant]
Official Action Dated Jul. 7, 2023 from the US Patent and Trademark Office Re. U.S. Appl. No. 17/253,176. (83 pages). [cited by applicant]
Communication Pursuant to Article 94(3) EPC Dated Nov. 7, 2023 From the European Patent Office Re. Application No. 19820226.9 (7 Pages). [cited by applicant]
Supplementary European Search Report and the European Search Opinion Dated Feb. 16, 2022 From the European Patent Office Re. Application No. 19820226.9. (8 Pages). [cited by applicant]
Grounds of Reason of Rejection Dated Apr. 25, 2024 From the Korean Intellectual Property Office Re. Application No. 10-2021-7001558 (7 Pages). [cited by applicant]
Requisition by the Examiner Dated Apr. 24, 2024 From the Innovation, Science and Economic Development Canada, Canadian Intellectual Property Office Re. Application No. 3,103,772 and Claims. (8 Pages). [cited by applicant]
Notice of Reason(s) for Rejection Dated Nov. 2, 2021 From the Japan Patent Office Re. Application No. 2019-533071 and Its Translation Into English. (9 Pages). [cited by applicant]
Notification of Office Action and Search Report Dated Sep. 9, 2022 From the China National Intellectual Property Administration Re. Application No. 201780085562.2. (8 Pages). [cited by applicant]
Restriction Official Action Dated Sep. 18, 2024 from the US Patent and Trademark Office Re. U.S. Appl. No. 17/792,149. (6 pages). [cited by applicant]
Requisition by the Examiner Dated Aug. 10, 2023 From the Innovation, Science and Economic Development Canada, Canadian Intellectual Property Office Re. Application No. 3,103,772. (4 Pages). [cited by applicant]
International Preliminary Report on Patentability Dated Jul. 28, 2022 From the International Bureau of WIPO Re. Application No. PCT/IB2021/050253. (13 Pages). [cited by applicant]
Official Action Dated Feb. 3, 2023 from the US Patent and Trademark Office Re. U.S. Appl. No. 17/895,124. (33 pages). [cited by applicant]
Official Action Dated Jul. 8, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 16/954,554. (69 pages). [cited by applicant]
Notice of Allowance Dated Jun. 1, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 17/251,829. (45 pages). [cited by applicant]
Examination Report Dated Feb. 28, 2024 From the Australian Government, IP Australia Re. Application No. 2019291582. (5 Pages). [cited by applicant]
Grounds of Reason of Rejection Dated May 26, 2022 From the Korean Intellectual Property Office Re. Application No. 2010-7029927. (3 Pages). [cited by applicant]
Official Action Dated Jun. 8, 2022 from US Patent and Trademark Office Re. U.S. Appl. No. 16/469,165. (78 pages). [cited by applicant]
Examination Report Dated Dec. 11, 2024 From the Australian Government, IP Australia Re. Application No. 2019291582. (3 Pages). [cited by applicant]